Eikon Therapeutics, Inc. (EIKN)
NASDAQ · Manufacturing · Biological products, (no diagnostic substances)
$7.92−$0.3700 (−4.46%) on the dayAs of the close; data may be delayed.
EIKN price, last 12 months
Key stats
- Previous close
- $8.29
- Open
- $8.45
- Day range
- $7.87 – $8.47
- 52-week range
- $7.72 – $17.40
- Volume
- 377.2K
- Avg volume (20 days)
- 653.5K
- Market cap
- $429.0M
Performance
1W−11.5%
1M−33.9%
3M−30.8%
6M−24.8%
YTD—
1Y—
Technicals and fundamentals
About Eikon Therapeutics, Inc.
Eikon Therapeutics Inc is a late-stage clinical biopharmaceutical company dedicated to building a world-wide , fully-integrated organization developing important, medicines to address serious unmet medical needs. It operates in a single operating segment, which is in the business of drug discovery leveraging its proprietary technology and clinical development of its product candidates. Its product candidates include: EIK1001, EIK1003, EIK1004, EIK1005, and EIK1006.
- Sector
- Manufacturing
- Industry
- Biological products, (no diagnostic substances)
- Listed on
- NASDAQ
- Market cap
- $429.0M